Inclusion Criteria:
  -  Participant in the SURVIVE registry
  -  Signed informed consent form for PROACT
  -  Histological diagnosis of early or metastatic breast cancer, lymphoma, sarcoma, leukemia, myeloma, or lung cancer (patients with treated and clinically stable brain metastasis are acceptable)
  -  Scheduled to receive anti-cancer therapy (radiation therapy is permitted)
Exclusion Criteria:
  -  Contraindication to magnetic resonance imaging (MRI)
  -  Unable to comply with study investigations (in the judgment of the investigator)
  -  Life expectancy less than 1 year